Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any familial isolated dilated cardiomyopathy in which the cause of the disease is a mutation in the ACTN2 gene.
Features include always present findings: Cardiomyocyte hypertrophy, Endocardial fibroelastosis, Thickened heart muscle (hypertrophic cardiomyopathy), and Endocardial fibrosis and others; and common findings: Myofiber disarray. 12 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 10 | Cardiac arrest, Atrial fibrillation, Left ventricular noncompaction |
ACTN2 encodes actinin alpha 2 (894 aa). F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein Highest expression in Muscle Skeletal (1,297 TPM) and Heart Left Ventricle (586.9 TPM).
Dilated cardiomyopathy 1AA is associated with mutations in the ACTN2 gene on chromosome 1.
The ACTN2 protein participates in CaMKII and LRRC7 bind to NMDA receptors at postsynaptic density and Negative regulation of NMDA receptor-mediated neuronal transmission pathways.
ACTN2 is classified as a druggable target (Druggable Genome and Transporter categories) with score 4.7.
82 pathogenic variants reported in ACTN2 in ClinVar, including hotspot variants 1220240 and 986096.
Variant | Significance | Review Stars | Hotspot |
|---|---|---|---|
1220240 | Conflicting classifications of pathogenicity | — | Yes |
986096 | Conflicting classifications of pathogenicity | — | Yes |
934598 | Conflicting classifications of pathogenicity | — | Yes |
579798 | Conflicting classifications of pathogenicity | — | Yes |
463209 | Conflicting classifications of pathogenicity | — | Yes |
Genetic testing for ACTN2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for dilated cardiomyopathy 1AA has been reported in the published literature.
Phenotype severity distribution: 5 always present features, 1 common feature.
No clinical trials have been registered for dilated cardiomyopathy 1AA.
184 publications have been identified in PubMed for dilated cardiomyopathy 1AA. Research spans Basic Science / Preclinical (23%), Review / Meta-Analysis (19%), and Case Report / Case Series (18%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 37 | 23% |
Research summaries | 31 | 19% |
Patient case studies | 29 | 18% |
Clinical study results | 23 | 14% |
Testing and diagnosis research | 19 | 12% |
Disease patterns and progression | 18 | 11% |
Other research | 2 | 1% |
New treatment approaches | 2 | 1% |
Jiang J (2026). [PMID: 41580760](https://pubmed.ncbi.nlm.nih.gov/41580760/). *J Transl Med*. [Diagnostic / Biomarker]
Meena H (2026). [PMID: 42233914](https://pubmed.ncbi.nlm.nih.gov/42233914/). *JACC Case Rep*. [Case Report / Case Series]
Wei M (2026). [PMID: 41540467](https://pubmed.ncbi.nlm.nih.gov/41540467/). *Stem Cell Res Ther*. [Basic Science / Preclinical]
Nusrat A (2026). [PMID: 41477684](https://pubmed.ncbi.nlm.nih.gov/41477684/). *Circ Heart Fail*. [Basic Science / Preclinical]
Tang Q (2026). [PMID: 42243863](https://pubmed.ncbi.nlm.nih.gov/42243863/). *BMC Med*. [Basic Science / Preclinical]
Parodi A (2026). [PMID: 42238652](https://pubmed.ncbi.nlm.nih.gov/42238652/). *Rev Cardiovasc Med*. [Review / Meta-Analysis]
Manohar A (2026). [PMID: 40846526](https://pubmed.ncbi.nlm.nih.gov/40846526/). *J Cardiovasc Comput Tomogr*. [Diagnostic / Biomarker]
Wang Y (2026). [PMID: 41391576](https://pubmed.ncbi.nlm.nih.gov/41391576/). *Cardiovasc Pathol*. [Basic Science / Preclinical]
Arslan A (2026). [PMID: 42165793](https://pubmed.ncbi.nlm.nih.gov/42165793/). *Neuro Endocrinol Lett*. [Epidemiology / Natural History]
Sirohi A (2026). [PMID: 41953868](https://pubmed.ncbi.nlm.nih.gov/41953868/). *J Med Cases*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 1:46 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center